Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucion Venture Capital Group is a prominent Chinese venture capital firm headquartered in Jinan, Shandong. It holds the distinction of being the first venture capital company listed on the Shanghai Stock Exchange, trading under the symbol 600783. The firm primarily focuses on strategic investments in high-tech industries, with a significant emphasis on biotechnology, pharmaceuticals, and medical devices. Lucion provides comprehensive financial support and management consulting to its portfolio companies, aiming to foster innovation and industrial upgrading within the Chinese market. Its investment portfolio includes numerous leaders in the life sciences sector, ranging from drug developers to medical technology manufacturers. The group leverages its state-owned background to bridge the gap between government policy and private enterprise growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lucion Venture Capital Group.